The Vanguard Group 13D/13G Filings for Alexion Pharmaceuticals, Inc. (ALXN)

The Vanguard Group 13D and 13G filings for Alexion Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-02-10
10:30 am
Purchase
2020-12-3113GAlexion Pharmaceuticals, Inc.
ALXN
The Vanguard Group19,406,768
8.870%
2,642,351increase
(+15.76%)
Filing